| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.28 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |